IMMUNOSTIMULANTS

Nonspecific immunostimulation has progressed from crude microbially de rived substances to chemically defined drugs with selective effects on different components of the immune system. John Hadden describes how immunopharmacological analyses of structure-activity relationships, ph armacokinetics and immunopharmacodynamics have directed the effective use of these agents in disease models and suggest that they may be of value in combination with other therapies in the treatment of immunode ficiencies, cancer, infections and even autoimmune disorders.